Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.
Boosting efforts to fight antibiotic resistance, Stanford researchers have found that a thin membrane, thought to be just a shrink wrap around some bacterial cell walls, has structural properties critical for survival. Drugs that destroy the membrane could be a new approach to treating infection.
Fanconi anemia is a rare but deadly disease, and there are no good drugs to treat its root cause. Now, Stanford researchers are developing a test that could help kids with the disease and millions more with related conditions.
Polly Fordyce is an assistant professor of genetics and bioengineering at Stanford University and a faculty fellow of Stanford ChEM-H. The Fordyce Lab develops novel tools to study molecular interactions. In a recent paper published in the Proceedings of the National Academy of Sciences, Fordyce...
The only source of noscapine, a cough suppressant with potential anti-cancer properties, is opium poppies. Yet Stanford bioengineers have found a new way of producing the drug: reconstructing its biosynthetic pathway in yeast.
As Stanford engineers find new ways to push, pull and sometimes simply jiggle cells and even individual molecules, they’re also discovering microscopic answers to some of the biggest questions in biology and health.